CNN's Dr. Sanjay Gupta reports on the Covid-19 vaccine being developed by the biotechnology company Moderna, in partnership with the National Institutes of Health, that has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.
#CNN #News
- Covid-19 vaccine shows 'promising' immune response results ( Download)
- Coronavirus vaccine trial shows promising results but hurdles remain ( Download)
- Oxford Coronavirus Vaccine Shows Promising Results | NBC Nightly News ( Download)
- Covid-19: Oxford vaccine shows promising results, prompts immune response ( Download)
- COVID-19 vaccine trials show promising early results l ABC News ( Download)
- COVID-19: AstraZeneca-Oxford vaccine shows promising results among elderly ( Download)
- Moderna's coronavirus vaccine triggers immune response, deemed safe to move to Phase 3 testing ( Download)
- Promising results in early COVID-19 vaccine trial ( Download)
- Phase 2 results of Oxford, AstraZeneca vaccine trial show promising results ( Download)
- Oxford University coronavirus vaccine trials show promising results | ABC News ( Download)
- New COVID-19 vaccine candidate shows promising results ( Download)
- Oxford University’s COVID-19 Vaccine Shows Promising Results In Phase 1 and 2 Trials ( Download)
- Oxford's COVID-19 vaccine shows promising immune response in human trials ( Download)
- US Covid-19 vaccine trial shows promising early results ( Download)
- Preliminary results from two leading vaccine trials show promise ( Download)
